[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349501-105":59,"doc-detail-349501-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","global-landscape-and-temporal-trends-in-lifetime-risk-of-colorectal-cancer-in-185-countries-a-population-based-study","Global landscape and temporal trends in lifetime risk of colorectal cancer in 185 countries - a population-based study","","Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related mortality worldwide. This population-based study estimates regional and national differences in lifetime CRC incidence and mortality. CRC data were taken from GLOBOCAN 2022 for 185 countries, with population and all-cause mortality from the United Nations, stratified into 20 regions and by Human Development Index (HDI). Lifetime risk was calculated with a life-table approach adjusted for multiple primary cancers. In 2022, lifetime incidence was 2.69% and death risk 1.39%.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-landscape-and-temporal-trends-in-lifetime-risk-of-colorectal-cancer-in-185-countries-a-population-based-study/349501/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-landscape-and-temporal-trends-in-lifetime-risk-of-colorectal-cancer-in-185-countries-a-population-based-study/349501.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s main objective?","Question",{"text":113,"@type":114},"To estimate regional and national variations in lifetime colorectal cancer (CRC) risk worldwide, including both incidence and mortality.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were lifetime CRC risks estimated?",{"text":118,"@type":114},"CRC incidence data came from GLOBOCAN 2022, and population and all-cause mortality were sourced from the United Nations; lifetime risk used a life-table method adjusted for multiple primary cancers.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key findings for 2022?",{"text":122,"@type":114},"The lifetime risk of developing CRC was 2.69% and the lifetime risk of dying from CRC was 1.39%, with higher risk in men than women and colon cancer higher than rectal cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349501,1790131287,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Cancer Biol Med 2026. doi: 10.20892/j.issn.2095-3941.2025.0851  \nORIGINAL ARTICLE  \nGlobal landscape and temporal trends in lifetime risk of colorectal cancer in 185 countries: a population-based study  \nLi Li*, Kexin Sun*, Xiang Li*, Yifei Yao, Hengxi Li, Shaoming Wang, Wanqing Chen, Rongshou Zheng  \nOffice for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \n\n| ABSTRACT | Objective: Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related mortality worldwide. This study was aimed at estimating regional and national variations in lifetime CRC risk worldwide.\u003Cbr>Methods: CRC data were extracted from GLOBOCAN 2022, including 185 countries, and population and all-cause mortality data were sourced from the United Nations. The world was divided into 20 geographical regions and categorized by Human Development Index (HDI). Lifetime CRC risk was estimated with the life table method, adjusted for multiple primary cancers.\u003Cbr>Results: In 2022, the lifetime risks of developing and dying from CRC were 2.69%[95% confidence interval (CI): 2.68–2.70] and 1.39%(95% CI: 1.39–1.40), respectively. Men had a higher risk of colon cancer than rectal cancer, and higher CRC risk than women. Lifetime risk varied by region and HDI: regions with very high, high, moderate, and low HDI had incidence risks of 5.17%, 2.75%, 0.72%, and 0.57%, respectively, and mortality risks of 2.48%, 1.50%, 0.44%, and 0.41%, respectively. Australia/New Zealand had the highest incidence risk (7.41%, 95% CI: 7.30–7.52), and Northern Europe the highest mortality risk (3.28%, 95% CI: 3.24–3.32) . Risks were stable before 40 years of age, peaked in middle age, and declined after 70 years of age. Temporally, Thailand had the highest increasing trend in lifetime risk, whereas the United States and Austria showed a decreasing trend. |\n| --- | --- |\n| KEYWORDS | Conclusions: Lifetime CRC risk differs by subtype, sex, HDI, and geography, and residual risk gradually decreases with age. Targeted primary prevention strategies should be implemented in various countries and regions to mitigate CRC burden.\u003Cbr>Lifetime risk; colorectal cancer; incidence; mortality; epidemiology |\n\nIntroduction  \nGlobally, malignant neoplasms pose a major public health challenge: they are primary contributors to premature mortality, and they substantially affect healthcare systems and socioeconomic development1,2 . Colorectal cancer (CRC) has become one of the most common malignant tumors in cancer diseases, and it accounts for a large proportion of cancerrelated deaths. Current estimates suggest that the global cancer burden reached approximately 20 million incident cases in 2022, and the number of cancer deaths approached 9.7 million. Notably, CRC contributed nearly 1.93 million incident  \n*These authors contributed equally to this work.  \nCorrespondence to: Wanqing Chen and Rongshou Zheng  \nE-mail: [chenwq@cicams.ac.cn](chenwq@cicams.ac.cn) and [zhengrongshou@cicams.ac.cn](zhengrongshou@cicams.ac.cn)  \nORCID ID: [https://orcid.org/0000-0002-1159-1884 and](https://orcid.org/0000-0002-1159-1884 and) [https://orcid](https://orcid). org/0000-0003-4295-3398  \nReceived December 31, 2025; accepted July 2, 2026. Available [at www.cancerbiomed.org](at www.cancerbiomed.org)  \n©2026 The Authors. Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4 .0)  \ncases (representing approximately one-tenth of total new cancer diagnoses) and was associated with more than 900,000 deaths worldwide3. Recent trends in CRC show a paradoxical pattern: although the age-adjusted mortality rates have consistently declined, primarily because of advancements in early detection through endoscopic screening, substantial geographical disparities exist in CRC incidence. These variations are closely correlated with socioec","cbCailYGe2JstycF","https://ap.wps.com/l/cbCailYGe2JstycF","pdf",481938,12,"English","# Data sources and methods\n## Data sources\n## Stratification\n## Analysis\n# Abstract content highlights\n## Objective\n## Methods\n## Results","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"To estimate regional and national variations in lifetime colorectal cancer (CRC) risk worldwide, including both incidence and mortality.\"},{\"question\":\"How were lifetime CRC risks estimated?\",\"answer\":\"CRC incidence data came from GLOBOCAN 2022, and population and all-cause mortality were sourced from the United Nations; lifetime risk used a life-table method adjusted for multiple primary cancers.\"},{\"question\":\"What were the key findings for 2022?\",\"answer\":\"The lifetime risk of developing CRC was 2.69% and the lifetime risk of dying from CRC was 1.39%, with higher risk in men than women and colon cancer higher than rectal cancer.\"}]","Global landscape and temporal trends in lifetime risk of colorectal cancer in 185 countries - a population-based study | PDF",1790083900,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d47dac6f9dcc3a64676e7f64a29780e.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b4b99a74743ff93762bd39222ae4dc9.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af0417c666b56b2e7611f1bc1b9d773b.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/258df47c49175af6e949c5b87d8f325d.webp",980,1283]